This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Staskin DR, Tosenberg MT, Dahl NV, Polishuk PV, Zinner NR.Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions. International Journal of Clinical Practice 62: 27-38, No. 1, Jan 2008
Rights and permissions
About this article
Cite this article
Transdermal oxybutynin improves QOL in men with OAB. Pharmacoecon. Outcomes News 548, 1 (2008). https://doi.org/10.2165/00151234-200805480-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805480-00001